Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: a study by the Italian association of radiotherapy and clinical oncology (AIRO)
Tài liệu tham khảo
Sung, 2021, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660
Gandhi, 2013, Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study, Int J Radiat Oncol Biol Phys, 87, 542, 10.1016/j.ijrobp.2013.06.2059
Mell, 2017, Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: An international multicenter phase II clinical trial (INTERTECC-2), Int J Radiat Oncol Biol Phys, 97, 536, 10.1016/j.ijrobp.2016.11.027
Gay HA, Barthold HJ, O'Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas [published correction appears in Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):7]. Int J Radiat Oncol Biol Phys. 2012 July 1; 83(3): e353–e362. https://doi.org/10.1016/j.ijrobp.2012.01.023.
Haie-Meder, 2005, Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV, Radiother Oncol, 74, 235, 10.1016/j.radonc.2004.12.015
Pötter, 2006, Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology, Radiother Oncol, 78, 67, 10.1016/j.radonc.2005.11.014
Hellebust, 2010, Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy, Radiother Oncol, 96, 153, 10.1016/j.radonc.2010.06.004
Dimopoulos, 2012, Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy, Radiother Oncol, 103, 113, 10.1016/j.radonc.2011.12.024
Potter R, Kirisits C, Erickson B, et al. ICRU report no. 89. Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. J ICRU. 2013; 13(1-258). https://doi.org/10.1093/jicru/ndw027.
Mahantshetty, 2021, IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer, Radiother Oncol, 160, 273, 10.1016/j.radonc.2021.05.010
Bernard, 2017, Pelvic-Floor Properties in Women Reporting Urinary Incontinence After Surgery and Radiotherapy for Endometrial Cancer, Phys Ther, 97, 438, 10.1093/ptj/pzx012
Smeenk, 2012, Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy, Int J Radiat Oncol Biol Phys, 83, 636, 10.1016/j.ijrobp.2011.08.007
Manea, 2018, Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters, Int J Radiat Oncol Biol Phys, 101, 411, 10.1016/j.ijrobp.2018.02.004
Zakariaee, 2017, Association of bladder dose with late urinary side effects in cervical cancer high-dose-rate brachytherapy, Brachytherapy, 16, 1175, 10.1016/j.brachy.2017.07.001
Kirchheiner, 2014, Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study, Int J Radiat Oncol Biol Phys, 89, 88, 10.1016/j.ijrobp.2014.01.032
Cefaro, 2008, A Guide for Delineation of Lymph Nodal Clinical Target Volume in Radiation Therapy, Book, Springer
Caravatta, 2014, Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience, Radiat Oncol, 9, 10.1186/1748-717X-9-198
Caravatta, 2019, Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers, Acta Oncol, 58, 439, 10.1080/0284186X.2018.1546899
Kouwenhoven, 2009, Measuring the similarity of target volume delineations independent of the number of observers, Phys Med Biol, 54, 2863, 10.1088/0031-9155/54/9/018
Hanna, 2010, Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods, Clin Oncol (R Coll Radiol), 22, 515, 10.1016/j.clon.2010.05.006
Danielsson, 1980, Euclidean distance mapping, Comput Graph Image Process, 14, 227, 10.1016/0146-664X(80)90054-4
Jena, 2010, A novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes, Br J Radiol, 83, 44, 10.1259/bjr/27674581
Bisello, 2022, Dose-Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter-Multidisciplinary Practical Summary, Curr Oncol, 29, 7021, 10.3390/curroncol29100552
Bell, 2020, Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer, Brachytherapy, 19, 146, 10.1016/j.brachy.2020.01.002
Franco, 2018, Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e, Clin Transl Radiat Oncol, 11, 33
Cooper, 2000, Fecal incontinence: a clinical approach, Mt Sinai J Med, 67, 96
Fernández-Fraga, 2002, Significance of pelvic floor muscles in anal incontinence, Gastroenterology, 123, 1441, 10.1053/gast.2002.36586
Heemsbergen, 2005, Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy, Int J Radiat Oncol Biol Phys, 61, 1011, 10.1016/j.ijrobp.2004.07.724
Munbodh, 2008, Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer, Med Phys, 35, 2137, 10.1118/1.2907707
Inokuchi, 2017, Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice, Clin Transl Radiat Oncol, 6, 31
Palorini, 2016, Bladder dose-surface maps and urinary toxicity: Robustness with respect to motion in assessing local dose effects, Phys Med, 32, 506, 10.1016/j.ejmp.2016.03.006
Spampinato, 2020, MRI-based contouring of functional sub-structures of the lower urinary tract in gynaecological radiotherapy, Radiother Oncol, 145, 117, 10.1016/j.radonc.2019.12.011
Rahn, 2007, Anatomic relationships of the distal third of the pelvic ureter, trigone, and urethra in unembalmed female cadavers, Am J Obstet Gynecol, 197, 668.e1, 10.1016/j.ajog.2007.08.068
Veera, 2019, Dedicated MRI simulation for cervical cancer radiation treatment planning: Assessing the impact on clinical target volume delineation, J Med Imaging Radiat Oncol, 63, 236, 10.1111/1754-9485.12831
Lim, 2015, Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios, Pract Radiat Oncol, 5, e557, 10.1016/j.prro.2015.06.011
Annede, 2018, Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachiterapy for cervical cancer, Brachyterapy, 922, 10.1016/j.brachy.2018.07.005
Kirchheiner, 2016, Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study, Radiother Oncol, 118, 160, 10.1016/j.radonc.2015.12.025
Singh, 2017, Dose-volume correlation of cumulative vaginal doses and late toxicity after adjuvant external radiation and brachytherapy for cervical cancer, Brachytherapy, 16, 855, 10.1016/j.brachy.2017.03.008
Susko, 2016, Vaginal dose is associated with toxicity in image guided tandem ring or ovoid-based brachytherapy, Int J Radiat Oncol Biol Phys, 94, 1099, 10.1016/j.ijrobp.2015.12.360
Lucia, 2021, Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer, J Pers Med, 11, 398, 10.3390/jpm11050398
Kovtun, 2017, Ovary-Sparing Radiation Planning Techniques Can Achieve Ovarian Dose Reduction for Soft Tissue Sarcoma of the Buttock and Thigh, Sarcoma, 2017, 2796925, 10.1155/2017/2796925
Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol 2014;26:185e196. https://doi.org/ 10.1016/j.clon.2013.11.031.
Kirwan, 2003, A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer, Radiother Oncol, 68, 217, 10.1016/S0167-8140(03)00197-X
Lei, 2019, Long-Term Survival and Late Toxicity Associated With Pelvic Intensity Modulated Radiation Therapy (IMRT) for Cervical Cancer Involving CT-Based Positive Lymph Nodes, Front Oncol, 9, 10.3389/fonc.2019.00520
Corbeau, 2021, Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review, Radiother Oncol, 164, 128, 10.1016/j.radonc.2021.09.009
Huang, 2020, Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial, Radiat Oncol, 15, 180, 10.1186/s13014-020-01606-3
Gupta, 2019, Potential Advantages of Bone Marrow Sparing IMRT in Cancer Cervix: A Dosimetric Evaluation, J Clin Diagn Res, 10.7860/JCDR/2019/39841.12745